Soluble receptors for cytokines and growth factors

International Archives of Allergy and Immunology

Volumn 111, Issue 2, 1996, Pages 99-106

  Müller Newen, Gerhard ^a   Köhne, Christian ^a   Heinrich, Peter C ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Agonistic action; Antagonists; Cytokines; Growth factors; Shedding; Soluble receptors; Splicing

Indexed keywords

CYTOKINE RECEPTOR; GROWTH FACTOR RECEPTOR;

IMMUNE SYSTEM; PRIORITY JOURNAL; REVIEW;

EID: 0029763280     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237353     Document Type: Article

References (58)

1. Fernandez-Botran R: Soluble cytokine receptors: Their role in immunoregulation. FASEB J 1991:5:2567-2574.
2. Rose-John S, Heinrich PC: Soluble receptors for cytokines and growth factors: Generation and biological function. Biochem J 1994:300: 281-290.
3. Heaney ML, Golde DW: Soluble cytokine receptors. Blood 1996:87:847-857.
4. Barron C, Migliaccio AR, Migliaccio G, Jiang Y, Adamson JW, Ottolenghi S: Alternatively spliced mRNAs encoding soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrow. Gene 1994:147:263-268.
5. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer VIC, Barr PJ, Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994:263:1759-1762.
6. Edens A, Southard JN, Talamantes F: Mouse growth hormone-binding protein and growth hormone receptor transcripts are produced from a single gene by alternative splicing. Endocrinology 1994;135:2802-2805.
7. Abramovich C, Ratovitski E, Lundgren E, Revel M: Identification of mRNAs encoding two different soluble forms of the human interferon alpha-reccptor. FEBS Lett 1994:338:295-300.
8. Novick D, Cohen B, Rubinstein M: The human interferon alpha beta receptor: Characterization and molecular cloning. Cell 1994:77:391-400.
9. Kendall RL, Thomas KA: Inhibition of vascular endothelial all growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993:90:10705-10709.
10. Sotiropoulos A, Goujon L, Simonin G, Kelly PA, Postel-Vinay MC, Finidori J: Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor. Endocrinology 1993; 132: 1863-1865.
11. Galvani AP, Cristiani C, Carpinelli P, Landonio A, Bcrtolero F: Suramin modulates cellular levels of hepatocyte growth factor receptor by inducing shedding of a soluble form. Biochem Pharmacol 1995:50:959-966.
12. Downing JR, Roussel MF, Sherr CJ: Ligand and protein kinase C down-modulate the colony-stimulating factor I receptor by independent mechanisms. Mol Cell Biol 1989;9:2890-2896.
13. Davis S, Aldrich HI, Ip NY, Stahl N, Scherer S, Farruggella T, DiStcfano PS, Curtis R, Panayo-tatos N, Gascan H, Chevalier S, Yancopoulos GD: Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses. Science 1993:259:1736-1739.
14. Brakebusch C, Nophar Y, Kemper O, Engel-mann H, Wallach D: Cytoplasmic truncation of the p55 tumour necrosis factor (INF) receptor abolishes signalling, but not induced shedding of the receptor. EMBOJ 1992:11:943-950.
15. Miillberg J, Schooltink H, Stoyan T, Günther M, Graeve L, Buse G, Mackicwicz A, Ileinrich PC, Rose-John S: The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 1993:23:473-480.
16. Crowe PD, Walter BN, Mohler KM, Otten-Evans C, Black RA, Ware CF: A metallopro-tease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in I lymphocytes. J Exp Med 1995:181:1205-1210
17. Miillberg J, Durie FH, Ottenevans C, Alderson MR, Rose-John S, Cosman D, Black RA, Mohler KM: A metalloproteasc inhibitor blocks shedding of the 11.-6 receptor and the p60 TNF receptor. Immunol 1995;155:5198-5205.
18. Miillberg J, Oberthur W, Lottspeieh F, Mehl E, Dittrich E, Graeve L, Heinrich PC, Rose-John S: The soluble human 11.-6 receptor. Mutational characterization of the proteolytic cleavage site. J Immunol 1994;152:4958-4968.
19. Brakcbuseh C, Varfolomeev EE, Batkin M, Wallach D: Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor. J Biol Chem 1994:269:32488-32496.
20. Lust JA, Donovan KA, Kline MP, Grcipp PR, Kyle RA, Maihle NJ: Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 1992:4:96-100.
21. Horiuchi S, Koyanagi Y, Zhou Y, Miyamoto H, Tanaka Y, Waki M, Matsumoto A, Yamamoto M, Yamamoto N: Soluble interleukin-6 receptor released from T cell or granulocyte macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol 1994:24:1945-1948.
22. Muller-Newen G, Kdhne C, Keul R, Hemmann U, Muller-Esterl W, Wijdenes J, Brakenhoff J PJ, Hart MHL, Heinrich PC: Purification and characterization of the soluble intcrlcukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. Eur J Biochem 1996:236:837-842.
23. Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpcl SD. Van den Bos T, Friend D, Alpert A, Anderson D, Jackson J, Wignall JM, Smith C, Gallis B, Sims JE, Urdai D, Widmer MB, Cosman D, Park LS: The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms. Cell 1989:59:335-348.
24. Tavemier J, Tuypens T, Piactinek G, Verhee A, Fiers W, Devos R: Molecular basis of the membrane-anchored and two soluble isofonns of the human interleukin 5 receptor alpha subunit. Proc Natl Acad Sci USA 1992:89:7041-7045.
25. Tomida M, Yamamoto YY, Hozumi M: Three different cDNAs encoding mouse D-factor LIT receptor. J Biochem (Tokyo) 1994:115:557-562
26. Alcami A, Smith GL: Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol Today 1995:16:474-478.
27. Symons JA, Alcami A, Smith GL: Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 1995:81:551-560.
28. Weiergraber O, Hemmann U, Kiister A, Muller-Newen G, Schneider J, Rose-John S, Kurschat P, Brakenhoff J PJ, Hurt MHL, Stabel S, Heinrich PC: Soluble human interleukin-6 receptor: Expression in insect cells, purification and characterization. Eur J Biochem 1995:234: 661-669.
29. De Vos AM, Ultseh M, Kossiakol TAA: Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 1992:255:306-312.
30. Somers W, Ultseh M, De Vos AM, KossiakolT AA: The X-ray structure of a growth hormone-prolactin receptor complex. Nature 1994:372; 478-481.
31. Banner DW, D'Arcy A, Janes W, Gcntz R, Schoenfeld H-J, Broger C, Loetscher H, Less-lauer W: Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation. Cell 1993:73:431-445.
32. Walter MR, Windsor WT, Nagabhushan TL, Lundell DJ, Lunn CA, Zauodny IJ, Narula SK: Crystal structure of a complex between interfe-ron-y and its soluble high-affinity receptor. Nature 1995;376:230-235.
33. Taga T, Flibi M, Hirata Y, Yamasaki K, Yasuka-wa K, Matsuda T, Hirano T, Kishimoto T: ln-terleukin-6 triggers the association of its receptor with a possible signal transducer, yp 130. Cell 1989:58:573-581.
34. Mackiewicz A, Schooltink FI, Fleinrich PC, Rose-John S: Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol 1992; 149:2021-2027.
35. Hirota H, Yoshida K, Kishimoto T, Taga T: Continuous activation of gp 130. a signal-transducing receptor component for interleukin 6-relat-ed cytokines, causes myocardial hypertrophy in mice. Proc Natl Aead Sci USA 1995:92:4862-4866.
36. Hanneken A, Ying W, Ling N, Baird A: Identification of soluble forms of the fibroblast growth factor receptor in blood. Proc Natl Acad Sci USA 1994:91:9170-9174.
37. Papa V, Russo P, Gliozzo B, Goldfine ID, Vi-gneri R, Pezzino V: An intact and functional soluble form of the insulin receptor is secreted by cultured cells. Endocrinology 1993; 133: 1369-1376.
38. Wypych J, Bennett LG, Schwartz MG, Clog-ston CL, Lu HS, Broudy VC, Bartley TD, Parker VP, Langley KE: Soluble kit receptor in human serum. Blood 1995;85:66-73.
39. Ruhl S, Pluznik DH, Feldman GM: Soluble in-tcrleukin-4 receptor production by murine myeloid progenitor cells: Induction by interleukin-6 and interfcron-y. Cytokine 1993:5:144-149.
40. Yamaguchi M, Mammoto A, Taga T, Kishimoto T, Miyake A: Regulation of mouse soluble in-tcrlcukin-6 receptor secretion by decidua. Bio-chem Biophys Res Contmun 1995:211:1077-1082.
41. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW: lnterleukin-6 (I L-6) as an anti-inflammatory cytokine: Induction of circulating IL-I receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994:83:113-118.
42. Van der Poll T, Fischer E, Coyle SM, Van Zee KJ, Pribblc JP, Stiles DM, Baric PS, Buurman WA, Moldawer LL, Lowry SF: Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis. J Infect Dis 1995; 172:577-580.
43. Colotta F, Saccani S, Giri JG, Dower SK, Sims JE, Introna M, Manotvani A: Regulated expression and release of the IL-I decoy receptor in human mononuclear phagocytes. J Immunol 1996;156:2534-2541.
44. Chilton PM, Femandez-Botran R: Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4. J Immunol 1993:151:5907-5917.
45. Heaney ML, Vera JC, Raines A, Golde DW: Membrane-associated and soluble granulocyte/ macrophage-colony-stimulating factor receptor subunit are independently regulated in 111.-60 cells. Proc Natl Aead Sci'USA 1995:92:2365-2369.
46. Honda M, Yamamoto S, Cheng M, Yasukawa K, Suzuki H, Saito T, Osugi Y, Tokunaga T, Kishimoto T: Human soluble IL-6 receptor: Its detection and enhanced release by HIV infection. J Immunol 1992;148:2175-2180.
47. De Bcnedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A: Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994:93:2114-2119.
48. Suzuki H, Yasukawa K, Saito T, Narazaki M, Hasegawa A, Taga T, Kishimoto T: Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal. Eur J Immunol 1993:23:1078-1082.
49. Zangerle R, Fuchs D, Sarcletti M, Gallati FI, Reibnegger G, Wachter H, Dierich MP, Most J: Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in FI IV infection. Clin Immunol Immunopathol 1994: 72:328-334.
50. Aderka D, Wysenbeek A, Engelmann FI, Cope AP, Brennan F, Molad Y, Flornik V, Levo Y, Maini RN, Feldmann M, Wallach D: Correlation between scrum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993:36: 1111-1120.
51. Howard OM, Clouse KA, Smith C, Goodwin RG, Farrar WL: Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation. Proc Natl Acad Sci USA 1993;90:2335-2339.
52. Ulich TR, Yi ES, Yin S, Smith C, Remick D: Intratracheal administration of endotoxin and cytokines. VII. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II;p80) inhibit acute inflammation. Clin Immunol Immunopathol 1994;72:137-140.
53. Nicolctti F, Di Marco R, Barecllini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Meroni P: Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. EurJ Immunol 1994:24:1843-1847.
54. Mullarkcy MF, Leiferman KM, Peters MS, Caro I, Roux ER, Hanna RK, Rubin AS, Jacobs CA: Human cutaneous allergic late-phase response is inhibited by soluble IL-I receptor. J Immunol 1994;152:2033-2041.
55. Sato TA, Widmer MB, Finkelman ID, Madani H, Jacobs CA, Grabstein KH, Maliszewski CR: Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J Immunol 1993;150:2717-2723.
56. Kleir, B, Wijdenes J, Zhang XG, Jourdan M, Boiron JM, Brochier J, Liautard J, Merlin M, Clement C, Morel-Foumier B, et al: Murine an-ti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 1991:78:1198-1204.
57. Lu ZY, Brochier J, Wijdencs J, Brailly H, Bataille R, Klein B: Fligh amounts of circulating interleukin (IL)-6 in the form of monomeric immune complexes during anti-IL-6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo. EurJ Immunol 1992:22:2819-2824.
58. Klein B, Brailly H: Cytokine-binding proteins: Stimulating antagonists. Immunol Today 1995: 16:216-220.